Elevated Plus Maze
Objective: Measure anxiety-like behavior by assessing exploration of open versus closed arms in mice subjected to chronic social defeat stress
This is a Elevated Plus Maze protocol using mouse as the model organism. The procedure involves 5 procedural steps, 1 equipment items, 4 materials. Extracted from a 2022 paper published in Journal of Neuroinflammation.
Model and subjects
mouse • Not specified • unknown • Not specified • Not specified
Study window
~1.5 hours hands-on
Core workflow
Chronic Social Defeat Stress (CSDS) Model Implementation • Inhibitor Administration (if applicable) • EDA Treatment Administration
Primary readouts
- Exploration of open arms versus closed arms
- Anxiety-like behavior indicators
- Time spent in open versus closed arms
- Frequency of arm entries
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Chronic Social Defeat Stress (CSDS) Model Implementation
Establish depression model in mice through chronic social defeat stress protocol
Note: This is the baseline stress condition for all subsequent behavioral tests
View evidence from paper
“A chronic social defeat stress (CSDS) depression model was performed to explore whether EDA could produce antidepressant effects”
Inhibitor Administration (if applicable)
Inject EX527 (Sirt1 inhibitor) and ML385 (Nrf2 inhibitor) intraperitoneally 30 minutes before EDA injection daily
Note: Intraperitoneal injection route; timing is critical - 30 minutes prior to EDA
View evidence from paper
“EX527, a Sirt1 inhibitor and ML385, a Nrf2 inhibitor were injected intraperitoneally 30 min before EDA injection daily”
EDA Treatment Administration
Administer EDA daily following inhibitor injection (if applicable)
Note: Administered after 30-minute interval from inhibitor injection
View evidence from paper
“EX527, a Sirt1 inhibitor and ML385, a Nrf2 inhibitor were injected intraperitoneally 30 min before EDA injection daily”
Elevated Plus Maze Test
Place mouse in elevated plus maze apparatus and measure anxiety-like behavior through assessment of exploration patterns in open versus closed arms
Note: One of multiple behavioral tests performed to assess depressive, anxiety-like and cognitive behaviors
View evidence from paper
“Behaviors tests were carried out to examine depressive, anxiety-like and cognitive behaviors including social interaction (SI) test, sucrose preference test (SPT), open field test (OFT), elevated plus maze (EPM)”
AAV Vector Infusion (for Gpx4 knockdown experiments)
Perform adeno-associated virus vector containing miRNAi (Gpx4)–EGFP infusion to determine effects of Gpx4 on CSDS mice with EDA treatment
Note: Knockdown experiments performed as separate experimental condition
View evidence from paper
“Knockdown experiments were performed to determine the effects of Gpx4 on CSDS mice with EDA treatment by an adeno-associated virus (AAV) vector containing miRNAi (Gpx4)–EGFP infusion”